Tesamorelin
Tesamorelin
Regulatory Status
A peptide with an established pharmaceutical history that still intersects with broader compounding policy debates.
FDA · Updated Apr 2026
Availability depends on licensed access pathways.
MHRA · Updated Apr 2026
Prescription-only context where available.
TGA · Updated Apr 2026
Growth-hormone signaling class remains restricted in sport.
WADA · Updated Apr 2026
Overview
Tesamorelin stands out because it has a clearer clinical lineage than many research peptides. That makes it a useful reference point when discussing how the FDA may differentiate between better-characterized compounds and the broader gray-market peptide ecosystem.
Continue Reading
Readers also explore
Sermorelin
Sermorelin Acetate
Growth hormone signaling · Body composition research
Open profileCJC-1295
CJC-1295 with Drug Affinity Complex
growth hormone optimisation · body composition · sleep quality
Open profileIpamorelin
Ipamorelin Acetate
growth hormone release · muscle growth · fat loss
Open profileState of Peptides 2026
Get the free report and peptide profile updates.
Evidence notes, regulatory changes, and practical research guides in your inbox. Education only - not medical advice.
Get the PeptideUnicorn update
New profiles, regulatory changes, practical guides, and vendor review notes delivered to your inbox.
Get our free State of Peptides 2026 report when you subscribe.